Read more about GeneReader NGS System
The first complete Sample to Insight NGS solution.
hero image
Webinar

Advancing forensic DNA quantification with eight-dye dPCR

Upcoming
icon_0085_cc_gen_calendar-s
Dec 1, 2026
icon_0175_ls_qf_operating_hours-s
4:00 PM (GMT+0)
+1 other
0Days0Hours0Minutes0Seconds

You will learn

icon_0153_cc_gen_source_okay-s

How digital PCR can improve forensic DNA quantification

Understand how absolute quantification using digital PCR (dPCR) can address limitations of standard curve-based qPCR methods.
icon_0153_cc_gen_source_okay-s

Development of an eight-dye multiplex assay

Learn how an eight-target assay was developed using the QIAGEN QIAcuity dPCR Platform to simultaneously quantify nuclear, male and mitochondrial DNA targets with an internal positive control.
icon_0153_cc_gen_source_okay-s

Evaluating assay performance for forensic samples

Review the assay's sensitivity, species specificity, inhibitor tolerance and fluorescence crosstalk correction.
icon_0153_cc_gen_source_okay-s

Applications in forensic casework

See how the assay was evaluated using mock casework samples and its potential to streamline sample triage while conserving limited evidentiary material

About this webinar

Accurate DNA quantification is critical for determining the appropriate analytical approach in forensic investigations. Conventional workflows often require separate quantitative PCR (qPCR) assays for nuclear and mitochondrial DNA, increasing sample consumption, processing time and reagent requirements.

In this webinar, Dr. Priyankaa Bhatia from the FBI Laboratory Division, Research and Support Unit will discuss the development and evaluation of an eight-dye digital PCR assay using the QIAGEN QIAcuity dPCR Platform. The assay simultaneously measures nuclear, male and mitochondrial DNA targets alongside an internal positive control. Learn how the assay was optimized and evaluated for sensitivity, specificity, inhibitor tolerance and performance with mock casework samples. The findings demonstrate the potential of multiplex dPCR to improve forensic sample triage and support downstream analysis decisions while preserving valuable evidence.

This work is the result of a forthcoming Collaborative Research and Development Agreement (CRADA) between the Federal Bureau of Investigation Federal Laboratory and QIAGEN Sciences Inc.

Names of commercial manufacturers are provided for identification purposes only, and inclusion does not imply endorsement of the manufacturer or its products or services by the FBI. Any reproduction or other use of these presentation materials without the express written consent of the FBI is prohibited. The views expressed are those of the author(s) and do not necessarily reflect the official policy or position of the U.S. Government.

Speakers

Fill out the form to take part in the event

Related events